Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas

Oncology. 1974;29(3):244-8. doi: 10.1159/000224906.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Administration, Oral
  • Carmustine / administration & dosage*
  • Carmustine / adverse effects
  • Carmustine / therapeutic use
  • Colonic Neoplasms / drug therapy*
  • Diarrhea / chemically induced
  • Fluorouracil / administration & dosage*
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use
  • Hematocrit
  • Humans
  • Injections, Intravenous
  • Leukopenia / chemically induced
  • Nausea / chemically induced
  • Neoplasm Metastasis
  • Nitrosourea Compounds / administration & dosage
  • Nitrosourea Compounds / therapeutic use
  • Stomach Neoplasms / drug therapy*
  • Thrombocytopenia / chemically induced
  • Time Factors
  • Vomiting / chemically induced

Substances

  • Nitrosourea Compounds
  • Fluorouracil
  • Carmustine